Hyperphosphorylated and aggregated tau disrupts mitochondrial axonal transport and dynamics, while mitochondrial dysfunction promotes tau pathology in AD (Cheng & Bai 2018). The gene discussed is MAPT; the disease is Alzheimer disease.